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Human papillomavirus (HPV) is one of the leading sexually transmitted 
infections (STIs). In males, persistent infection with high-risk HPV types 
(mainly types 16 and 18) can cause penile cancer, anal cancer and 
oropharyngeal cancer1, and low-risk HPV types (mainly type 6 and 11) are 
associated with anogenital warts and mild dysplasia2. Compared to 
heterosexual males, men who have sex with men (MSM) have significantly 
higher prevalence of HPV and HPV-related morbidities3. A systematic review 
and meta-analysis found that in China, the HPV prevalence in MSM (59.9%, 
95% confidence interval52.2% to 67.6%) was significantly higher than that in 
heterosexual men (OR=8.81, 8.01 to 9.69)4. A meta-analysis published in 
2021 found in China, the estimated prevalence of anal HPV among MSM was 
85.1% (HIV-positive), 53.6% (HIV-negative) and 59.2% (unknown HIV 
status)5. 
 
The quadrivalent and nonavalent HPV vaccines have been proved to be 
both efficacious and cost-effective in preventing HPV-related morbidities in 
males6-9. In recent decades, an increasing number of countries are including 
males into their national HPV vaccination programs. In China, males are still 
excluded from the HPV vaccination strategy. It is important to understand the 








implementation of vaccination policy. However nationwide data on the 
acceptability of HPV vaccination or intention to initiate HPV vaccination among 
MSM are scarce. Sporadic surveys in China showed the HPV vaccination 
intention among MSM fluctuated greatly, ranging from 18.8% in Wuxi to 73.5% 
in Hangzhou10 11. In high-income counties, studies about the knowledge and 
attitude of HPV vaccination among target populations were published, before 
the commencement of the national vaccination programs1213. This inspired us 
to carry out the research in mainland China in order to inform future males’ 
HPV vaccination strategies. 
 
The objectives of this study were to assess the following items among 
MSM in China: 1) intention to initiate HPV vaccination and its associated 
factors; 2) knowledge of and attitude towards HPV and HPV vaccine. 2) 
facilitators of and barriers against HPV vaccination.  
 
2. Material and methods 
 
2.1. Study design and ethics statement 
Data used in this paper were from the baseline survey of a randomized 
controlled trial assessing the efficacy of social-networking-app-based 
intervention in improving the knowledge of and intention to initiate HPV 








Ethics Committee of School of Public Health, Sun Yat-sen University (2019008) 
and was registered on the Chinese Clinical Trial Registry Website 
(http://www.chictr.org.cn, registration #: ChiCTR1900020981). Participants 
provided written consent.  
 
2.2 Participants and sampling 
We designed a poster including brief program introduction and QR code of 
the questionnaire, and then posted it at MSM community-based organizations 
(CBOs) or HIV Voluntary Counselling and Testing (VCT) clinics affiliated to 
local Centers for Disease Control and Prevention (CDCs). The recruitment 
was conducted in six sites, namely Shanghai and Wuxi in east China, Qingdao 
in north China, and Shenzhen, Guangzhou and Foshan in southern China, 
January to March 2019. The sampling method was convenient sampling. 
Trained volunteers introduced our study to every male coming for testing or 
counseling. After reading study information shown on the poster, men willing to 
participate could access the eligibility screening questionnaire by scanning the 
QR code. We calculated the sample size based on the following formula: 





× 𝑆2. N represents the total sample size in either 
intervention group or control group. s represents polled standard deviation of 
both groups. δ represents the significant difference between effect values, α
=0.05, power=90%. The inclusion criteria were: 1) men aged 18 years and 








bisexual, or had anal or oral sex with another man. Eligible participants were 
randomized into intervention group and control group in a ratio of 1:1. We 
pushed tailored message about HPV and HPV vaccine and sexual health 
education to men in the intervention group, and pushed message about sexual 
health education only to men in the control group at the same frequency via 
Wechat (a smartphone-based instant messaging app widely used in China, 
equivalent to Whatsapp)14. The primary outcome was the intention to initiate 
HPV vaccination within 6 months. 
 
2.3 Data collection 
The questionnaire was developed via three steps: 1) Drafting the original 
version by referring to previous related papers based on social cognition 
approaches or behavioral prediction models3 15 16 . 2) Making a revision to 
adjust to the local context by working with 9 academics, professors majoring in 
public health and managers of NGOs. 3) Conducting a pilot study at the 
participating site in Guangzhou to verify the practicability. 
 
Eligible participants completed a questionnaire to collect information on: 1) 
demographics such as age, educational level and monthly income 2) 
knowledge about HPV and HPV vaccine 3) PMT constructs and HPV 
vaccination intention 4) evaluation about the government’s publicity for males’ 








for not initiating 6) whether willing to recommend it to people around them. The 
Likert scale was employed to create options for answer such as three-point 
scale ‘Extremely’, ‘Moderately’ and ‘Not at all’ as answers of question ‘The 
level of impact on daily life if MSM get infected with HPV’ belonging to the PMT 
variable ‘severity’. 
 
2.4 Variables and measurements 
2.4.1 Demographic characteristics 
Age, educational level, occupation, monthly income, marital status and 
sexual orientation were included in the demographic characteristics. 
 
2.4.2 Knowledge of HPV and HPV vaccine 
This variable was measured using 7 items, 4 for HPV knowledge (e.g. ‘if 
males have risk of HPV infection?’) and 3 for HPV vaccine knowledge (e.g. 
‘What diseases can be prevented for males by getting HPV vaccine?’). The 
total score was used as an exogenous variable in the structural equation 
model (SEM) and a higher score indicated a higher knowledge level of HPV 
and HPV vaccine. 
 
2.4.3 PMT scale 
The Protection Motivation Theory (PMT) consists of two independent 








focusing on threat and factors that increase or decrease the probability of 
maladaptive responses, consists of intrinsic and extrinsic rewards, severity 
and vulnerability. Coping appraisal, focusing on threat and factors that 
increase or decrease the probability of adaptive response, consists of 
response efficacy, self-efficacy and response costs. Minimizing threat 
appraisal while maximizing the coping appraisal helps develop the intention to 
initiate protective actions, which facilitates actual protective behaviors. The 
PMT explains the intrinsic mechanism and process of behavior 
transformation18 and has been widely used in recent decades as a framework 
for explaining harmful behaviors such as smoking19 or predicting protective 
behaviors such as disease screening20. Because there is no conceptual 
distinction between the reward value of risk behavior and cost of preventative 
measure21, the following five factors are normally included in a PMT model: 
severity, vulnerability, response efficacy, self-efficacy and response costs22. 
For example, the meaning of the opinion that ‘not taking HPV vaccine would 
save money’ is equivalent to the opinion that ‘taking HPV vaccine would cost 
money’. We also included these five factors in our PMT model.  
 
2.4.3.1 Threat appraisal 
This construct consisted of two subconstructs: perceived severity (5 items) 
and perceived vulnerability (4 items). Perceived severity was designed to 








HPV (e.g. ‘Evaluation  about the possibility of getting genital warts for MSM 
after infection with HPV’). Perceived vulnerability meant participants’ 
assessment for the level of susceptibility of infection with HPV (e.g. ‘Evaluation 
about the possibility of infection with HPV in your daily life’). A higher score 
indicated perceived more severity and vulnerability respectively. 
 
2.4.3.2 Coping appraisal 
Coping appraisal consisted of response efficacy, self-efficacy and 
response costs. Response efficacy represented individuals’ evaluation about 
the perceived effectiveness of getting the HPV vaccine for MSM (e.g. ‘How 
strong the belief that HPV vaccine can reduce the risk of having genital warts’). 
Self-efficacy was used to assess one’s belief of the ability in one’s own 
confidence to get the first dose and complete all three doses of HPV vaccine 
(e.g. ‘I will be able to purchase HPV vaccine when I want to’). Response costs 
were used to measure one’s perceived cost of taking HPV vaccine (e.g. ‘I have 
the ability to cover the total cost of three doses of HPV vaccine’). For all three 
subconstructs, higher score meant higher motivation to take action. 
 
2.4.3.3 Intention to initiate HPV vaccination 
The behavioral intention was assessed by a single item. Participants were 
asked ‘How likely will you initiate HPV vaccination within the next 6 months?’ 







including three dose of vaccination and extra fare). A 5-point Likert scale was 
used to evaluate the level of intention (from ‘very high’ to ‘very low’). The 
higher score meant a higher level of intention. In addition, the participants were 
asked about the opinions towards the government’s publicity about males’ 
HPV vaccination, the reason why they have not taken the HPV vaccine and 
whether they were willing to recommend HPV vaccine to their peers. 
 
2.5 Statistical analysis  
For descriptive analysis, mean, standard deviation (SD) and range were 
used to describe quantitative variables like age. A number of cases and 
percentage were applied to describe other categorical variables like 
occupation. SEM is a systematic instrument to evaluate the relations among 
latent variables and theoretical models in the field of sociology, etc. Complete 
SEM construction consisted of two parts: measurement model which is 
primitively based on confirmatory factor analysis (CFA) and structural model 
which is built by path analysis. The measurement model is used to verify the 
relation between observed variables and latent variables, reflecting the quality 
of the questionnaire. The structural model is applied to explore the relationship 
among latent variables and to verify the theoretical model. The following 
statistical analysis process was described by these two parts.  
 








The measurement models were built by CFA. Factor loading of each item 
was used to evaluate the weight of influence in corresponding measurement 
models. Items whose factor loading values were lower than 0.5 were deleted 
from the scale and the final measurement models were guaranteed to include 
at least three items 23. The final measurement models were tested by two 
metrics: construct validity and composite reliability (CR). The definition of the 
construct validity was mainly divided into two indicators: convergent and 
discriminate validities. The absolute value of standardized factor loading 
should be more than 0.5. The average variance extracted (AVE) criterion 
should be more than 0.5 to ensure good convergent validity. The discriminate 
validity was assured when the square root of AVEs were both larger than the 
correlation coefficients of these two subconstructs. The composite reliability for 
each of the study’s constructs should be all above the recommended 0.7 level 
to indicate good internal consistency 24.  
 
2.5.2 Assessment of the structural model 
One-way ANOVA was used to compare the knowledge score among 
different intention levels to initiate HPV vaccination. Maximum Likelihood 
Method was used in the process of constructing a structural equation model 
and Mardia’s Kurtosis test was applied to evaluate multivariate normality25. 
The p-value for assessing the significance of path coefficient was set at 0.05. 








were used for evaluating the fitting performance of the structural model: 
chi-square/𝒹 ratio, goodness of fit (GFI), adjusted goodness of fit (AGFI), 
comparative fit index (CFI), standardized root mean square residual (SRMR) 
and the root mean square error of approximation (RMSEA). The latent 
variables are represented by elliptical shapes and the observed variables are 
represented by rectangular shapes in the path diagram. All analyses were 




3.1 Demographics of participants 
A total of 610 men participated in the study, and 47 were excluded from the 
analysis because of incomplete answers and low quality of questionnaire 
(those completed within less than 5 minutes). The final sample size was 563 
(response rate: 92.3%) from six sites, namely 55 from Foshan, 105 from 
Guangzhou, 102 from Qingdao, 109 from Shanghai, 92 from Shenzhen and 
100 from Wuxi. 
 
The mean age was 28.0 year (SD: 6.8). The majority (67.7%) had an 
educational level of technical diploma/undergraduate. For occupational 
distribution, except 13.3% were students and 12.3% were unemployed, most 








monthly income of RMB 2000 – 5999 (USD 285-857). For marital status, most 
participants were unmarried (single or common-law relationship) (84.7%) and 
for sexual orientation, most reported homosexual (76.0%). All demographic 
results were shown in Table 1. 
 
3.2 Knowledge about HPV and HPV vaccine 
The mean score of knowledge was 1.59 (range 0-11). Only 27% of 
participants knew HPV vaccine also applies to males and 60% never heard of 
the HPV vaccine.  The average score or proportion of correct answer for each 
item were also shown in table 4. There was statistically significant difference 
among different levels of intention groups (P<0.001) thus the knowledge was 
considered to be included in the structural model as a covariate variable.  
 
3.3 Measurement model  
The factor loadings of final items remaining in each measurement model, 
higher than 0.5, are presented in Table 2. For subconstruct perceived severity, 
the highest item loading was ‘the perceived possibility of getting genital warts 
after infection with HPV’ (0.884, P=0.048), reflecting the fear for infection of 
genital warts among participants. For perceived vulnerability, the highest item 
loading was ‘the possibility of infection with HPV in your daily life’ (0.851, 
P=0.032), again indicating fear for infection of genital warts. Similarly, the 








reduce the risk of having genital warts’ (0.941, P=0.020). As for self-efficacy, 
item that ‘I am sure I can complete the whole procedure of HPV vaccination 
once I get the first dose’ had the highest item loading (0.719, P=0.001).  
 
Table 3 describes the mean, SD, CR, AVE and correlation coefficients of 
each subconstruct. The CRs were all above 0.7 indicating good internal 
consistency of the data and the AVEs were not less than 0.5 indicating good 
convergent validity. Meanwhile, the square root of AVEs were larger than all 
other correlation coefficients, showing acceptable discriminate validity. 
 
3.4 Structural model 
The rate of intention among 563 participants were 18.1% for ‘very high’, 
25.2% for ‘above average’, 41.4% for ‘unsure’, 9.8% for ‘below average’ and 
5.5% for ‘very low’, respectively. Figure 1 shows the schematic map of the 
structural model with solid lines indicating standardized regression weights 
(P=0.010). The knowledge (the standardized total effect was 0.298, P=0.021) 
and the perceived severity (0.049, P<0.001) had indirect effect on the intention. 
The self-efficacy (0.093, P=0.011), response efficacy (0.172, P=0.020) and 
perceived vulnerability (0.230, P<0.001) had direct effect on the intention. 
Different from the hypothesized theory, the response costs had no effect on 
the outcome intention variable. The fit of the structural model was as following: 










3.5 Attitudes towards government’s policies and reasons for not initiating HPV 
vaccination 
For the question ‘whether you expect the government’s approval and 
promotion of HPV vaccination for MSM in the future?’, 84.2% participants 
agreed. For the question ‘Would you like to recommend HPV vaccine to MSM 
around you?’, 86.1% chose yes. As for the government policy, 26.1% of 
participants thought the publicity about the HPV vaccination for MSM was 
insufficient and 34.8% thought it was extremely insufficient. For the question 
‘Do you think if it is necessary for the government to subsidize HPV 
vaccination for MSM’, 63.8% thought it is definitely necessary (Table 4). Figure 
2 shows reasons why participants had not taken HPV vaccine and the 
proportion of people who agreed with this statement. The top 3 answers were 
‘did not know where to get HPV vaccine’ (49.4%), ‘did not get HPV vaccination 




Our study found that the knowledge about HPV and HPV vaccine among 
Chinese MSM was suboptimal and the intention to initiate HPV vaccination 








as to improve awareness and intention to initiate HPV vaccination.  
 
Our study participants were young (73.2% were≤30 years). Studies found 
that young MSM had higher prevalence of high risk sexual behaviors26 2728. 
However, sexual health education was lacking for most of the schools, 
especially in rural areas, still less about HPV29 30. The median age at first anal 
intercourse had been decreasing steadily from 33 years of age among MSM 
born from 1940 to 1959 to 18 years of age among MSM born from 1990 to 
1996. This age is expected to decrease further among MSM born after the 
1990s31. This points to the necessity of HPV educational intervention as early 
as possible and the inclusion of males in the national HPV immunization plan 
in China. Over half (56.3%) of participants’ monthly income were less than 
RMB 5999 (USD 857). The majority of MSM would found it strenuous to afford 
HPV vaccine (ranging from RMB 2400, 343 dollars for 4v HPV vaccine to RMB 
4000, 572 dollars for 9v HPV vaccine). This accorded with the reason why they 
would not initiate HPV vaccination (40.0% chose ‘the cost is too high’). 
Congruously, 85.1% thought the government should subsidize HPV 
vaccination program. For the knowledge level, the mean score of knowledge 
about HPV and HPV vaccination was much lower than that among 
gay/bisexual or MSM in high-income countries3 32. This phenomenon could be 
partly attributed to the publicity education deficiency from the health authority 








towards MSM HPV vaccination was insufficient or extremely insufficient in 
China. 
 
Except for response costs in PMT, other variables had influence, direct or 
indirect, on the intention to initiate HPV vaccination (Knowledge level and 
perceived severity had indirect effect. Vulnerability, response efficacy and 
self-efficacy had direct effect). Similar to many PMT-related studies, the 
knowledge level had indirect effect by influencing other variables, illustrating 
that gaining relevant knowledge could both increase threat appraisal and 
coping appraisal20 33. The path analysis showed perceived vulnerability 
mediated the association between perceived severity and intention. 
Participants might reevaluate the possibility of infection and serious outcomes 
if they were infected with HPV. Additionally, there was a conflict between no 
influence of response cost on the intention and the proportion result of the 
answer for the reason why they haven’t initiated HPV vaccination (40.0% 
chose ‘the economy cost is too high’). Perhaps it could be attributed to the 
main barrier of the cost for preventing MSM from initiating HPV vaccination, 
compared to other items involved in response costs such as time consumption, 
side effect and fear of needles or pain. Consequently, the total effect of this 
variable is not statistically significant. 
 








and promotion of HPV vaccination for MSM in the future. As of 2019, more 
than 100 countries have introduced national HPV vaccination programs34 and 
an increasing number of countries are including boys and MSM. For example, 
the US licensed quadrivalent HPV vaccine for boys and young men in 2009, 3 
years after girls. Quadrivalent HPV vaccine was recommended for boys aged 
11-21 years and also MSM through the age of 2635. However, in China, there 
is no national HPV vaccination for males even the HPV prevalence is not 
optimistic36. We hope our study will help remind the health authority in China to 
increase publicity of HPV vaccination and consider subsidizing HPV 
vaccination for MSM. Except the choice ‘the cost is too high’, the other top two 
reasons for why they did not get HPV vaccine were ‘did not know where to get 
HPV vaccine’ and ‘did not get HPV vaccination recommendation from health 
care providers’. Consequently, not only for MSM, education should also be 
implemented on health care providers. 
 
Our study has limitations. Study sites are economically well-off cities. MSM 
resident in rural regions were not recruited. As a result, our sample may not 
represent MSM from rural regions in China. The outcome was the perceived 
intention to initiate HPV vaccination, rather than the actual uptake. There might 
be a gap between these two stages. Despite these limitations, this study 
evaluated HPV vaccination intention and explored its influencing factors, which 








studies are warranted for this group of population to verify the availability of 
PMT-based education in China. The results of the model had potential ability 
to inspire the following intervention studies and health education. For example, 
based on the factor loading results, in term of the subconstruct perceived 
severity, education could focus on the negative influence on the quality of life 
and severe outcomes of HPV infection among MSM, i.e. anal cancer and 
genital warts.  
 
In conclusion, the knowledge about HPV and HPV vaccine among 
Chinese MSM was suboptimal and the intention to initiate HPV vaccination 
was low. Knowledge level, perceived severity, perceived vulnerability and 
self-efficacy affect the intention to initiate HPV vaccination. MSM should be 
included in HPV vaccination strategies. Future HPV vaccination strategies 
should address these issues and involve both science and policy-making. 
Cost-effectiveness studies are needed to inform future HPV vaccination 
policies among MSM in China. 
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Table 1. Demographic characteristics of participants 
 
Variable N (%) 









Junior high school or less 40 (7.1) 
Senior high school/junior college 107 (19.0) 
Technical secondary school/undergraduate 381 (67.7) 
Post-undergraduate and above 35 (6.2) 
Occupation  
Student 75 (13.3) 
Unemployed 69 (12.3) 
Employed 419 (74.4) 
Personal monthly income (Chinese yuan)  
< 2000  66 (11.7) 
2000 - 5999  251 (44.6) 
6000 - 9999  159 (28.2) 
> 10000  87 (15.5) 
Marital status   
Married with a woman 64 (11.4) 
Married with a man (marriage registration 
abroad) 
0 (0.0) 
Unmarried (single or common-law 
relationship) 
477 (84.7) 








Sexual orientation  
Homosexual 428 (76.0) 
Bisexual 112 (19.9) 
Heterosexual 2 (0.4) 
Unsure 21 (3.7) 
 
Table 2. The questionnaire’s items and their item loadings 
 
Construct Item (Mean score/ Proportion for correct answer)* Scale Measurement 
Item 
loading 
Severity 1) The level of impact on daily life if MSM get 
infected with HPV (4.32) 
Extremely high 5 
Not at all 1 
0.673 
2) The possibility MSM get genital warts after 
infection with HPV? (4.33) 
0.884 
3) The possibility MSM get cancers (anal, 
penile, head and neck, oropharyngeal 
cancers, etc) after infection with HPV? 
(4.16) 
0.731 
Vulnerability 1) The possibility of contacting HPV in your 
daily life (3.13) Extremely high 5 
Not at all 1 
0.851 
2) The possibility of infecting HPV in your 









3) In your opinion, the prevalence of HPV 
among MSM in China is (2.80) 
High 4  None 1 
0.581 





1) Getting the HPV vaccine can reduce the 
risk of genital warts (4.03) 
Strongly agree 5 
Strongly disagree 1 
0.941 
2) Getting the HPV vaccine can reduce the 
risk of HPV-related cancer (3.97)  
0.891 
3) Getting the HPV vaccine can improve the 
quality of your life (3.96) 
0.799 
Self-efficacy 1) You can decide if you need HPV 
vaccination (4.15) 
Strongly agree 5 
Strongly disagree 1 
0.699 
2) You are sure you can get the opportunity of 
HPV vaccination whenever you want (3.54) 
0.686 
3) You are sure you can complete the whole 
procedure of HPV vaccination once you get 




1) Males have a risk of HPV infection (37.8%) Ture 1  False 0 — 
2) HPV infection can be treated with antibiotic 
(11.2%) 
Ture 0  False 1 — 
3) HPV infection can be cured completely 
(18.7%) 








4) HPV infection is hereditary (17.6%) Ture 0  False 1 — 
5) HPV vaccine could apply to males (27.0%) Ture 1  False 0 — 
6) What diseases can be prevented by getting 
the HPV vaccine？(0.37) 
□Anogenital warts     □Syphilis 
□Anal cancer         □Oropharyngeal 
cancer 
□Penis cancer        □Gonorrhea 
□Intraepithelial lesion  □HIV/AIDS 
□Unknown 
0-5 (9 options, 5 
true answers. Each 
true answer for 1 
score) 
— 
7) How many doses the whole procedure of 
HPV vaccination involve？(9.2%) 
One dose 0 
Two doses 0 





1) How likely is it that you will initiate HPV 
vaccination within the next 6 months? 
(3.41) 
Very High 5 
Very low 1 
— 
*Rather than the mean score, the proportion for correct answer was chosen to be shown 
for logical questions in ‘Knowledge Level’ part. 
 
Table 3. Descriptive statistics, composite reliability (CR), average variance 
extracted 









Construct Mean SD CR AVE 
Construct 
1 2 3 4 5 6 
Knowledge 1.59 2.29 — — —      
Severity 17.17 2.12 0.81 0.59 -0.009 0.77     
Vulnerability 11.93 2.96 0.80 0.50 0.222** 0.088* 0.71    
Response 
Efficacy 
11.96 2.43 0.91 0.77 0.196** 0.222* 0.312** 0.88   
Self-Efficacy 11.75 2.31 0.74 0.50 0.159** 0.131* 0.247** 0.612** 0.71  
Intention 3.41 1.06 — — 0.153** -0.005 0.269** 0.272** 0.226** — 
Notes: 1. The bold fonts in the leading diagonals are the square root of AVEs. 
Off-diagonal elements are correlations among constructs. 
      2. SD: Standard Deviation, CR: Composite Reliability, AVE: Average Variance 
Extracted. 
 
Table 4. Attitude towards government policy on HPV vaccination for MSM 
Question Answer for option N(%) 
Whether you expect the government's 
approval and promotion of HPV 
vaccination for MSM in the future? 
Yes, I expect 474 (84.2) 
No, I do not expect 24 (4.3) 
I do not care 65 (11.5) 








vaccine to your MSM peers around you? No, I would not 78 (13.9) 
What do you think of the publicity about 
HPV vaccination for MSM from the 
government 
Extremely sufficient 45 (8.0) 
Sufficient 38 (5.7) 
Unsure 137 (24.3) 
Insufficient 147 (26.1) 
Extremely insufficient 196 (34.8) 
Do you think if the government should 
subsidize HPV vaccination for MSM? 
Needed greatly 359 (63.8) 
Needed 120 (21.3) 
Unsure 70 (12.4) 
Did not need 12 (2.1) 




Figure 1. The path diagram of structural model 
Illustration: It is a schematic map of the structural modeling result with solid 
lines indicating standardized regression weights (P<0.05) of each latent 
variable. 
 
Figure 2. Reasons why MSM had not initiated HPV vaccination 
Illustration：It shows the proportion of answers for the multiple choice questions 








Thinking the vaccine was only for females; B: Thinking males could not get 
vaccine in mainland China; C: Not knowing where to get HPV vaccine; D: Lack 
of HPV vaccination recommendation from health care providers; E: Price of 
HPV vaccine too high; F: Not having time to get HPV vaccine; G: Not knowing 
enough about the vaccine; H: Being afraid of needles or perceived pain; I: 
























Response Efficacy  
Self-Efficacy 
Intention to Initiate 












A: Thinking the vaccine was only for females  
B: Thinking males could not get vaccine in mainland China  
C: Not knowing where to get HPV vaccine  
D: Lack of HPV vaccination recommendation from health care providers  
E: Price of HPV vaccine too high  
F: Not having time to get HPV vaccine 
G: Not knowing enough about the vaccine  
H: Being afraid of needles or perceived pain  
I: Worrying about sexual orientation disclosure 
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Would you like to recommend HPV vaccine  
to your MSM peers around you?  




Whether you expect the government's approval 
and promotion of HPV vaccination for MSM in 
the future? 





Do you think if the government should 
subsidize HPV vaccination for MSM? 
Needed  greatly Needed
Unsure Did not need






What do you think of the publicity about HPV 













A: Thinking the vaccine was only for females  
B: Thinking males could not get vaccine in mainland China  
C: Not knowing where to get HPV vaccine  
D: Lack of HPV vaccination recommendation from health care providers  
E: Price of HPV vaccine too high  
F: Not having time to get HPV vaccine 
G: Not knowing enough about the vaccine  
H: Being afraid of needles or perceived pain  
I: Worrying about sexual orientation disclosure 












































 Low level of knowledge and intention to initiate HPV vaccination among MSM 
in China. 
 Most variables of The Protection Motivation Theory were associated factors. 
 Tailored intervention should be applied among MSM in China. 
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